跳至主要内容
临床试验/NCT01576458
NCT01576458已完成3 期

Randomised Placebo-controlled Study of Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 1998年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
20
试验地点
1
主要终点
pruritus

研究概览

简要总结

The purpose of this study is to examine the efficacy and safety of ursodeoxycholic acid (UDCA) in the treatment of patients with intrahepatic cholestasis of pregnancy (ICP).

In the randomised (double-blind, placebo-controlled) study 20 pregnant women with ICP received (random allocation of) either 450 mg/day UDCA or placebo for 14 days during the third trimester of pregnancy. The severity of pruritus was registered. Itching scores and serum levels of alanine aminotransferase, total bile acids, estradiol, progesterone, prolactin, cholesterol, HDL-cholesterol, triglycerides, activated partial thromboplastin time (APTT), fibrinogen D-dimers (FIDD) and platelet count were assessed before the treatment and weekly thereafter. Data on pregnancy and delivery outcome was recorded and analysed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

性别
Female
接受健康志愿者

入选标准

  • Pregnant women with intrahepatic cholestasis of pregnancy

排除标准

  • 未提供

研究组 & 干预措施

ursodeoxycholic acid

Active Comparator

10 pregant women with intrahepatic cholestasis of pregnancy

干预措施: ursodeoxycholic acid (Drug)

placebo

Active Comparator

10 pregnant women with intrahepatic cholestasis of pregnancy

干预措施: Placebo (Drug)

结局指标

主要结局

pruritus

时间窗: an average of 5 weeks

visual analogy scale (VAS): 0-10

laboratory values

时间窗: an average 5 weeks

Serum levels of alanine aminotransferases and total bile acids were assessed before the treatment and once a week thereafter at least three times or until delivery. Simultaneously serum levels of estradiol, progesterone, prolactin, cholesterol, HDL-cholesterol and triglyserides were assessed. Platelet count activated partial thromboplastin time and fibrinogen D-dimers were measured as well.

次要结局

  • Obstetrical surveillance(2-12 weeks)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Titta Joutsiniemi

MD

Turku University Hospital

研究点 (1)

Loading locations...

相似试验